Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 14Cr 12Cr 12Cr 11Cr 20Cr 1.35TCr 20Cr 138.67Cr 54Cr 685.92Cr 53Cr 52Cr 2.21TCr | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 11Cr 9.83Cr 18Cr 1.26TCr 18Cr 129.67Cr 50Cr 641.4Cr 49Cr 48Cr 2.06TCr | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.05% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 14Cr | ||
| +0.11% | +2.71% | +0.44% | +26.85% | 4.63TCr | ||
| -1.12% | +1.78% | +42.30% | +27.55% | 4.39TCr | ||
| -3.04% | -6.29% | +338.56% | +515.97% | 4.09TCr | ||
| -0.74% | +1.25% | +4.92% | +67.98% | 3.99TCr | ||
| -0.50% | +0.67% | +10.29% | +41.28% | 2.95TCr | ||
| -0.46% | +4.22% | +22.81% | +139.44% | 1.71TCr | ||
| -0.97% | -10.17% | - | - | 1.55TCr | ||
| -0.57% | +8.12% | +22.19% | +38.68% | 1.52TCr | ||
| -3.14% | +31.91% | -11.79% | - | 1.4TCr | ||
| Average | -1.80% | +3.76% | +53.72% | +122.54% | 2.92TCr | |
| Weighted average by Cap. | -1.10% | +1.87% | +68.04% | +130.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.24L 14.16L 13.37L 12.14L 22.75L 16Cr 22.84L 1.6Cr 61.8L 7.92Cr 61L 59.64L 25Cr | 1L 1L 1L 93.67T 2L 1.2Cr 2L 12.36L 5L 61.12L 5L 5L 1.97Cr |
| Net income | -1.27Cr -1.1Cr -1.04Cr -94.69L -1.77Cr -121.52Cr -1.78Cr -12Cr -4.82Cr -62Cr -4.76Cr -4.65Cr -198.79Cr | -23Cr -20Cr -19Cr -17Cr -33Cr -2.24TCr -33Cr -229.9Cr -89Cr -1.14TCr -88Cr -86Cr -3.66TCr |
| Net Debt | 13.96L 12.18L 11.5L 10.44L 19.56L 13Cr 19.64L 1.38Cr 53.14L 6.81Cr 52.45L 51.29L 22Cr | -91.25L -79.57L -75.13L -68.22L -1.28Cr -88Cr -1.28Cr -9Cr -3.47Cr -45Cr -3.43Cr -3.35Cr -143.23Cr |
Employees
-
















